FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

391761004: Amisulpride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2694945010 Amisulpride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2734395018 Amisulpride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
51731000195111 amisulpride it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
791011000172116 amisulpride fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
66001000195117 Amisulprid de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Amisulpride Is a Atypical antipsychotic false Inferred relationship Some
Amisulpride Is a Benzamide derivative antipsychotic agent false Inferred relationship Some
Amisulpride Is a Anti-psychotic agent (substance) true Inferred relationship Some
Amisulpride Is a Substance with benzamide structure true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Amisulpride 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some
Product containing amisulpride (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amisulpride Inferred relationship Some 1
Amisulpride 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some
Amisulpride 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some
Amisulpride 100mg/mL s/f oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some
Amisulpride 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some
Amisulpride 100mg/mL s/f oral solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some
Amisulpride 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some 1
Amisulpride 400 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Amisulpride 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some 1
Amisulpride 50 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Amisulpride 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some 1
Amisulpride 200 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Amisulpride 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Amisulpride Inferred relationship Some 1
Amisulpride 100 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Amisulpride 100 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Amisulpride 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Amisulpride 200 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Product containing amisulpride in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amisulpride Inferred relationship Some 1
Amisulpride 400 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Amisulpride 100 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Amisulpride 100 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Product containing only amisulpride (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amisulpride Inferred relationship Some 1
Product containing only amisulpride in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amisulpride Inferred relationship Some 1
Product containing only amisulpride in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amisulpride Inferred relationship Some 1
Product containing amisulpride in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amisulpride Inferred relationship Some 1
Amisulpride 100 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Amisulpride 100 mg prolonged-release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Product containing precisely amisulpride 100 milligram/1 each conventional release orodispersible tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Product containing precisely amisulpride 100 milligram/1 each conventional release orodispersible tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Product containing amisulpride in oromucosal dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amisulpride Inferred relationship Some 1
Amisulpride only product in oromucosal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Amisulpride Inferred relationship Some 1
Amisulpride 50 mg orodispersible tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Amisulpride 50 mg orodispersible tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Product containing precisely amisulpride 400 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Product containing precisely amisulpride 400 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1
Product containing precisely amisulpride 200 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Amisulpride Inferred relationship Some 1
Product containing precisely amisulpride 200 milligram/1 each prolonged-release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Amisulpride Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start